NEFL and Parkinson disease: A cohort study with a broad range of neurodegenerative diseases, including PSP, CBS, PD, PD with MCI, PDD, DLB, FTD, ALS, AD, and MCI, and healthy controls used ELISA to compare CSF NfL levels.